Encounter Resources EBITDA margin
Was ist das EBITDA margin von Encounter Resources?
EBITDA margin von Encounter Resources Limited ist -332.24%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Materials Sektor auf ASX im Vergleich zu Encounter Resources
Was macht Encounter Resources?
Encounter Resources Limited engages in the exploration and development of mineral deposits in Australia. It explores for zinc, copper, gold, and cobalt deposits. The company holds interests in the Lamil and Yeneena projects located in the Paterson Province, Western Australia. It also holds interests in the Aileron project situated in the West Arunta, Western Australia; and the Elliott copper project located in the Northern Territory. The company was incorporated in 2004 and is based in Subiaco, Australia.
Unternehmen mit ebitda margin ähnlich Encounter Resources
- Forbidden Spirits Distilling hat EBITDA margin von -336.58%
- European Metals hat EBITDA margin von -334.90%
- Carmat SA hat EBITDA margin von -333.29%
- La Jolla Pharmaceutical Co hat EBITDA margin von -333.27%
- Mabpharm hat EBITDA margin von -332.56%
- Elsight hat EBITDA margin von -332.42%
- Encounter Resources hat EBITDA margin von -332.24%
- Microba Life Sciences Ltd hat EBITDA margin von -331.80%
- Global Blood Therapeutics hat EBITDA margin von -330.50%
- Sienna Cancer Diagnostics hat EBITDA margin von -330.16%
- Nova Royalty hat EBITDA margin von -330.11%
- Vermillion hat EBITDA margin von -329.33%
- Clearside Biomedical Inc hat EBITDA margin von -329.31%